• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于外显子跳跃的替代寡核苷酸化学概述。

Overview of alternative oligonucleotide chemistries for exon skipping.

作者信息

Saleh Amer F, Arzumanov Andrey A, Gait Michael J

机构信息

Laboratory of Molecular Biology, Medical Research Council, Cambridge, UK.

出版信息

Methods Mol Biol. 2012;867:365-78. doi: 10.1007/978-1-61779-767-5_23.

DOI:10.1007/978-1-61779-767-5_23
PMID:22454073
Abstract

The chemistry of the oligonucleotide backbone is crucial to obtaining high activity in vivo in exon skipping applications. Apart from the ability to bind strongly and sequence-specifically to pre-mRNA targets, the type of backbone also influences cell delivery, in vivo pharmacology, bio-distribution, toxicology, and ultimately the therapeutic use in humans. Reviewed here are classes of oligonucleotide commonly used for exon skipping applications, namely negatively charged backbones typified by RNA analogues having 2'-O-substitution and a phosphorothioate linkage and charge-neutral backbones such as PNA and PMO. Also discussed are peptide conjugates of PNA and PMO that enhance cellular and in vivo delivery and their potential for drug development. Finally, the prospects for development of other analogue types in exon skipping applications are outlined.

摘要

在外显子跳跃应用中,寡核苷酸骨架的化学性质对于在体内获得高活性至关重要。除了能够与前体mRNA靶标进行强结合和序列特异性结合外,骨架类型还会影响细胞递送、体内药理学、生物分布、毒理学,最终影响其在人类中的治疗用途。本文综述了常用于外显子跳跃应用的寡核苷酸类别,即以具有2'-O-取代和硫代磷酸酯键的RNA类似物为代表的带负电荷骨架以及诸如肽核酸(PNA)和吗啉代寡核苷酸(PMO)等电荷中性骨架。还讨论了增强细胞和体内递送的PNA和PMO的肽缀合物及其在药物开发中的潜力。最后,概述了在外显子跳跃应用中开发其他类似物类型的前景。

相似文献

1
Overview of alternative oligonucleotide chemistries for exon skipping.用于外显子跳跃的替代寡核苷酸化学概述。
Methods Mol Biol. 2012;867:365-78. doi: 10.1007/978-1-61779-767-5_23.
2
In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.新型反义寡核苷酸的体外评估可预测杜氏肌营养不良症的体内外显子跳跃活性。
J Gene Med. 2010 Apr;12(4):354-64. doi: 10.1002/jgm.1446.
3
Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.2'-O-甲基硫代磷酸酯反义寡核苷酸的肽偶联增强 mdx 小鼠的心脏摄取和外显子跳跃。
Nucleic Acid Ther. 2014 Feb;24(1):25-36. doi: 10.1089/nat.2013.0448. Epub 2013 Dec 9.
4
Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries.反义寡核苷酸诱导的外显子跳跃与肌营养不良蛋白基因转录本:组合与化学方法
BMC Mol Biol. 2007 Jul 2;8:57. doi: 10.1186/1471-2199-8-57.
5
A chemical view of oligonucleotides for exon skipping and related drug applications.用于外显子跳跃及相关药物应用的寡核苷酸的化学视角。
Nucleic Acid Ther. 2014 Feb;24(1):37-47. doi: 10.1089/nat.2013.0454. Epub 2013 Oct 30.
6
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.2'-O-甲基硫代磷酸酯和吗啉代反义寡核苷酸用于杜氏肌营养不良症外显子跳跃的体内比较。
J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.
7
RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.基于 RNA 二级结构设计的反义肽核酸用于调节与疾病相关的异常 Tau 前体 mRNA 可变剪接。
Molecules. 2019 Aug 20;24(16):3020. doi: 10.3390/molecules24163020.
8
Renadirsen, a Novel 2'OMeRNA/ENA Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo.Renadirsen,一种新型 2'OMeRNA/ENA 嵌合反义寡核苷酸,在体内诱导肌营养不良蛋白外显子 45 的有效跳跃。
Curr Issues Mol Biol. 2021 Sep 25;43(3):1267-1281. doi: 10.3390/cimb43030090.
9
Terminal antisense oligonucleotide modifications can enhance induced exon skipping.末端反义寡核苷酸修饰可增强诱导外显子跳跃。
Neuromuscul Disord. 2005 Oct;15(9-10):622-9. doi: 10.1016/j.nmd.2005.06.009.
10
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.寡核苷酸对亲环素A前体mRNA剪接的核反义效应:三环DNA与锁核酸的比较
Nucleic Acids Res. 2004 Jan 15;32(1):346-53. doi: 10.1093/nar/gkh187. Print 2004.

引用本文的文献

1
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies.杜氏肌营养不良症:疾病机制与治疗策略。
Front Physiol. 2023 Jun 26;14:1183101. doi: 10.3389/fphys.2023.1183101. eCollection 2023.
2
Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy.当前杜氏肌营养不良症外显子跳跃试验概要。
Genes (Basel). 2022 Jul 14;13(7):1241. doi: 10.3390/genes13071241.
3
Preclinical Safety Assessment of Therapeutic Oligonucleotides.治疗性寡核苷酸的临床前安全性评估。
Methods Mol Biol. 2022;2434:355-370. doi: 10.1007/978-1-0716-2010-6_25.
4
Quantification of Antisense Oligonucleotides by Splint Ligation and Quantitative Polymerase Chain Reaction.通过衔接物连接和实时定量聚合酶链反应定量检测反义寡核苷酸。
Nucleic Acid Ther. 2022 Feb;32(1):66-73. doi: 10.1089/nat.2021.0040. Epub 2021 Dec 17.
5
Gene Therapy in Inherited Retinal Diseases: An Update on Current State of the Art.遗传性视网膜疾病的基因治疗:最新技术现状
Front Med (Lausanne). 2021 Oct 15;8:750586. doi: 10.3389/fmed.2021.750586. eCollection 2021.
6
Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases.用于炎症性肠病患者的治疗性寡核苷酸
Biologics. 2020 Jun 15;14:47-51. doi: 10.2147/BTT.S257638. eCollection 2020.
7
Inherited Retinal Disease Therapies Targeting Precursor Messenger Ribonucleic Acid.针对前体信使核糖核酸的遗传性视网膜疾病疗法
Vision (Basel). 2017 Sep 1;1(3):22. doi: 10.3390/vision1030022.
8
Fusion transcripts: Unexploited vulnerabilities in cancer?融合转录本:癌症未被开发的弱点?
Wiley Interdiscip Rev RNA. 2020 Jan;11(1):e1562. doi: 10.1002/wrna.1562. Epub 2019 Aug 13.
9
Oligonucleotide⁻Palladacycle Conjugates as Splice-Correcting Agents.寡核苷酸⁻钯环合物作为剪接校正剂。
Molecules. 2019 Mar 26;24(6):1180. doi: 10.3390/molecules24061180.
10
Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle.清道夫受体A1类介导吗啉代反义寡核苷酸进入营养不良性骨骼肌。
Mol Ther Nucleic Acids. 2019 Mar 1;14:520-535. doi: 10.1016/j.omtn.2019.01.008. Epub 2019 Jan 25.